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Tooth movement in orthodontics begins with insertion of elastomeric separators which are used to create the space for placement of band material around the tooth for attachment of bracket and auxiliaries are known to cause discomfort and pain to the patient in its initial days. Pain after separator placement increases gradually from the 4 th hour to the 24 th hour, but it subsides around the 7 th day. [5] An effective control of pain can have a huge impact on the perception of orthodontic care on the patient's mind and can significantly minimises the apprehension towards the treatment and in still a positive mental attitude towards the treatment.
NSAIDs have stood the test of time when it comes to pain management; however, they also come with an inherent property of being anti-inflammatory, thus basically acting against the theory of tooth movement. Paracetamol has a central site of action by inhibiting COX-3 centrally, thus not interfering with tooth movement, but it has been found that the efficacy of paracetamol is less than that of ibuprofen, which is peripherally acting non-selective COX inhibitor. It has been debated that single dose of NSAIDs is not sufficient enough to prevent tooth movement; however, the possibility still exists and the doors to search for alternatives remain wide open while considering ibuprofen as an established standard.
The purpose of the present study was to compare the efficacy of ibuprofen and Belladonna in the control of orthodontic pain and to ascertain the pain relief by Belladonna in comparison with ibuprofen during orthodontic separation.
Materials and MetHods
The study's experimental design and protocol were approved by the Ethical Committee of the ACPM Dental College, Dhule, Maharashtra, India. This study was conducted in Department of Orthodontics and Dentofacial Orthopedics of ACPM Dental College, Dhule, Maharashtra, India. Eighty patients, between 20 and 35 years of age, 51 females and 21 males, scheduled to undergo fixed appliance treatment, agreed to participate in the study. Patients were explained about the study, and informed consent was obtained from the patients. Cases with non-extraction treatment plan having proper contacts' mesial and distal to permanent first molar and currently not taking any analgesics or antibiotics were included in the study. Patients consuming analgesics or anti-inflammatory drugs or having a history of bronchial asthma, any history of hepatic or renal diseases, peptic ulceration or allergy to ibuprofen were excluded from the study.
Patients were randomly divided into two groups; one group was assigned to ibuprofen 400 mg and second group was allocated to Belladonna 6C group. In the Belladonna 6C group, four globules given to patient. Patients were given two doses of medication of their respective groups, 1 h before placement of elastomeric separators (Ormco Separators, Ormco Corporation, CA, USA) which was administered in the department and one dose 6 h after the placement.
A set of seven printed pages of visual analogue scale (VAS) along with instruction of how to record pain response (including local language) was given to patients. VAS was a 10 cm scale with millimetre calibration to record their pain at the following intervals: 2 h after placement, 6 h after placement, bedtime at 9 pm, day 1 morning, day 2 morning, day 3 morning and day 5 morning. Patients were asked to mark the appropriate response they felt on chewing and biting. Patients were instructed to call the attending doctor if he/she felt the pain unbearable so that necessary analgesic treatment can be administered to the patient.
Statistical analysis
Data were analysed using SPSS Inc. Released 2007. SPSS for Windows, Version 16.0. Chicago, SPSS Inc. Findings were summarised with the use of frequencies and percentages for categorical variables and means and standard deviations (SD) for continuous variables. Chi-square tests were used to compare proportion, and unpaired t-tests were used to compare the mean of continuous data in two groups. The null hypothesis presumed that there was no significant difference of the pain score at different time intervals which was the basis of analysis in between the two groups. Repeated measure ANOVA and simple effects tests were used to estimate VAS pain difference according to time and group. P values reported were two tailed and were considered significant at the 0.05 level.
results
In eighty patients, 51 (63.8%) females and 29 boys (36.3%) were included in the study. In ibuprofen group, 67.5% were female patients, and in Belladonna group, 60% were females. Mean age of patients in ibuprofen group was 21.8 (3, SD) years and in Belladonna group was 21.9 (3.2, SD) years [ Table 1 ]. There was statistically no significant difference in the sex (P = 0.485) and age (P = 0.914) of patients included in either of two groups [ Table 2 ].
Post hoc comparisons indicated that that there was no difference between the two groups at 2 h (P = 0.77), 6 h (0.073), 1 day (P = 0.120), 2 days (P = 0.283), 3 days (P = 0.363), 5 days (P = 0.622) and 7 days though the VAS pain was higher in Belladonna group than ibuprofen group [ Table 3 ]. Mean VAS pain score at different time intervals after separator placement in ibuprofen and Belladonna group is given in [ Figure 1 ].
There was a statistically significant effect of time on VAS pain score (F = 1383.1, P < 0.001), but there was no significant interaction between time and group (F = 1.02, P > 0.05). Indicating that there was no significant (P > 0.05) difference of pain score between the groups' different time intervals. Between subject, there was statistically no significant (F = 140, P > 0.05) difference of VAS pain in between the groups [ Table 4 ].
discussion
Pain experienced during orthodontic treatment is not trifling and needs to be taken care of from the first appointment with the orthodontist. Although a wide range of patient responses are present, pain and discomfort are generally experienced, which may instil a negative approach towards the treatment, or in very few cases may lead to discontinuation. [6] Minor et al. [7] found that preemptive administration of ibuprofen significantly reduces pain scores as compared to post-separator placement and placebo group, also the peak plasma level concentration of ibuprofen in blood reaches in [8] hence, administration of ibuprofen 1 h before placement of separators was decided for the study.
Previous studies that have been conducted to compare the efficacy of various NSAIDs showed that ibuprofen 400 mg is consistent in reducing the pain scores when compared to placebo groups; [5, 6] however, Naproxen sodium has proved to be better than ibuprofen and placebo groups, [5] whereas another study suggested that Naproxen sodium and paracetamol were at par to placebo groups. These previous studies show that conventional analgesics typically accepted by modern medicine may also fail to achieve the desired level of analgesia. However, ibuprofen had consistently proved its efficacy and also in the performed study. Gastric irritation is a common side effect possible with consumption of NSAIDs such as ibuprofen, although single dose administration clinically does not produce the aforementioned symptom; however, the potential of side effect still cannot be ruled out. Homoeopathic medications have no proven side effect.
The results of the present study indicated that peak pain levels were maximum after 24 h of placement and the average scores during the first 24 h of placement indicated that ibuprofen group was more effective than Belladonna 6C but here was no significant statistical difference present between the two groups in the first 24 h. Pain scores decreased after 24 h and but Belladonna 6C group scores were lesser than that of ibuprofen, which might be attributed to half-life of ibuprofen which is 1.8-2 h and the drug is completely eliminated from the system in 24 h. [9, 10] After 24 h, average Belladonna 6C pain scores are lower than ibuprofen group. 
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Comparación de la eficacia de ibuprofeno y Belladonna en el control del dolor ocasionado por separadores ortodónticos
Resumen-Fundamento-El objetivo de este estudio fue comparar la eficacia de ibuprofeno y Belladonnaen el control del dolor ortodóntico y determinar el alivio del dolor con Belladonnaen comparación con ibuprofeno durante la separación ortodóntica.
Métodos-En este estudio, se incluyeron pacientes, 51 mujeres y 21 varones, con edades entre los 20 y 35 años. Los pacientes se dividieron aleatoriamente en dos grupos, un grupo fue asignado a 400 mg de ibuprofeno y un segundo grupo aBelladona 6C. Los pacientes recibieron dos dosis de la medicación en los respectivos grupos, una dosis administrada en la consulta una hora antes de la colocación de los separadores elastoméricos(OrmcoSeparators, OrmcoCorporation, CA)y una dosis 6 horas tras la colocación. Las puntuaciones del dolor se registraron en la escala VAS(escala de 10 cm con un calibrado en mm) para determinar el dolor en los siguientes intervalos: 2 y 6 horas tras la colocación, en el momento de ir a dormir, día 1 mañana, día 2 mañana, día 3 mañana y día 5 mañana.
Resultados-Las comparaciones post hocindicaron que no hubo diferencias entre los dos grupos a las 2horas (p=0,77) y 6horas (0,073), así como en el día 1 (p=0,120), día 2(p=0,283), día 3(p=0,363), día 5 (p=0,622) y día 7.
Conclusiones-Ibuprofeno y Belladona 6C son eficaces y proporcionan una analgesia adecuada sin diferencias estadísticamente significativas. Debido a la falta de efectos adversos, Belladonna 6C constituye una alternativa eficaz y viable.
Comparaison de l'efficacité de l'Ibuprofène et de la Belladona pour contrôler la douleur provoquée par le séparateur orthodontique

Résumé:
Contexte: Le but de cette étude est de comparer l'efficacité de l'Ibuprofène et de la Belladona pour contrôler la douleur dentaire et de vérifier le soulagement de la douleur apporté par la Belladona par rapport à l'Ibuprofène durant la séparation orthodontique. 
Méthodes
